|University ||Rice University, B.A., Biochemistry/Economics; University of California at San Diego, Ph.D., Biomedical Sciences|
|Law School||Suffolk University, J.D.|
|Admitted||Massachusetts; registered to practice before U.S. Patent & Trademark Office|
Christopher is a member of the Intellectual Property Practice Group in the firm's Boston office. His practice involves the preparation and prosecution of U.S. and foreign patent applications primarily in the areas of biotechnology and biochemistry, particularly in the fields of oligonucleotide therapeutics, cell biology, genomics, immunology, microbiology and virology. Chris has extensive experience in the areas of patent procurement, performance of IP due diligence and preparation of non-infringement, invalidity and freedom-to-operate opinions. He counsels a diverse array of academic and biotechnology sector clients.
Chris' work has included direction of a large RNAi-relevant patent portfolio including prosecution of pending applications to issuance of broad claims of high value.
He has also prosecuted an international portfolio of applications for an immunological therapeutic agent now in clinical trials.
Before Edwards Wildman
Christopher was Director of Intellectual Property at a major pharmaceutical company, where he achieved issuance of multiple high-value patents protecting the company's oligonucleotide therapeutic technologies, managed programming efforts that integrated IP filtering into the company's lead agent selections, and directed the company's IP estate through several rounds of partnering and venture funding due diligence. Before his legal career, Chris was a Damon Runyon postdoctoral fellow in the laboratory of Dr. Eric Lander at the Whitehead/MIT Center for Genome Research (now known as the Broad Institute) and completed his Ph.D. in cell biology in the laboratory of Dr. Scott Emr at the University of California, San Diego.
Edwards Wildman Client Advisory - U.S. Patent and Trademark Office Issues Guidance in View of Prometheus and Myriad
Documents by this lawyer on Martindale.com
U.S. Patent and Trademark Office Issues Guidance in View of Prometheus and Myriad
Daniel W. Clarke,Peter F. Corless,Christopher R. Cowles,Ralph A. Loren, March 11, 2014
On March 4, 2014, the United States Patent and Trademark Office (USPTO) issued a highly anticipated Guidance for Determining Subject Matter Eligibility of Claims Reciting or Involving Laws of Nature, Natural Phenomena & Natural Products (“Guidance”). The Guidance is promulgated for...
|Profile Visibility |
|#1,970 in weekly profile views out of 19,418 lawyers in Boston, Massachusetts|
|#133,404 in weekly profile views out of 1,587,858 total lawyers Overall|